WAYNE, PA — Teleflex Incorporated (NYSE ... further support the integration and expansion of these advanced vascular solutions. Financial Outlook The acquired products demonstrated a constant ...
The acquisition of the Vascular Intervention business will also allow Teleflex the opportunity ... we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency ...
Teleflex is separating into two publicly traded companies to optimize growth and shareholder value. The acquisition of Biotronik's Vascular Intervention expands Teleflex's presence in coronary and ...
Teleflex's acquisition of BIOTRONIK's Vascular Intervention business enhances ... we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional ...
Teleflex's growth and profit outlook is strong ... 4.15 in 2017 due to the large acquisitions of NeoTract and Vascular Solutions, and leverage has averaged 2.7 times adjusted EBITDA over the ...
Teleflex RemainCo (“RemainCo”) will consist of Teleflex's Vascular Access ... we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional ...
Feb. 27, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated ... we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results